US Material Events SEC 8-K Filings — June 05, 2026

Material Events Monitor

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The June 5, 2026 Material Events Monitor reveals a clear bifurcation between capital-intensive companies facing liquidity crises and tech/industrial firms executing strategic pivots.

The most critical theme is **liquidity distress in capital-intensive sectors**: Americas Car-Mart (CRMT) secured only a 7-day lender forbearance while exploring strategic alternatives, and Phoenix Motor (PHOENIX) accepted a $5M term loan with onerous terms including a 49% equity option, signaling severe financing constraints. Conversely, the **AI and digital asset infrastructure sector** shows robust capital formation, with Bitmine Immersion Technologies (BMNR) upsizing a $273.8M preferred stock offering at 9.50% yield and Brand Engagement Network (BEN) completing a strategic AI-fleet investment. A notable **pattern of executive departures** spans 10+ companies, with several sudden resignations (Purple Innovation COO, Bionano Genomics CMO, Seadrill board dissent) weakening institutional knowledge. From period-over-period comparisons, **Gossamer Bio’s debt exchange** (90.5% tender, swapping 5% notes for 7.5% secured notes) reflects sector-wide refinancing stress. The most actionable insights cluster around **debt restructuring catalysts** (Seres Therapeutics, Gossamer Bio) and **mineral/energy asset digitization** (I-ON Digital, Northern Minerals), while the broad insider activity pattern of senior departures without named successors signals operational risk across multiple sectors.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from May 29, 2026.

Investment Signals (10)

  • Bitmine Immersion Technologies (BMNR) (BULLISH)

    Upsized $273.8M preferred offering at 9.50% yield, reducing equity dilution risk vs common equity. Proceeds target ETH/staking expansion. NYSE listing application filed (BMNP). Dividend step-up to 15% creates yield floor for income investors

  • Brand Engagement Network (BEN) (BULLISH)

    $1M strategic investment in HighTide Energy (Accelevate) at 20% premium to market ($17.82/share). AI-fleet intelligence platform targets 3 continents. Warrant to increase ownership from 10% to 20% positions BEN for exponential revenue growth

  • Seres Therapeutics (MCRB) (BULLISH)

    $25M VOWST milestone buyout from Nestlé + lease restructuring extends cash runway into Q1 2027. SER-155 Phase 2-ready with Breakthrough Therapy designation. Clinical data catalyst expected late June 2026

  • Gossamer Bio (GOSS)

    90.5% noteholder tender for 7.5% secured notes exchange reduces bankruptcy risk, but equity dilution from 254M new shares + 33M warrants caps upside. Net: refinancing risk removed, but cap table heavily diluted [NEUTRAL/BULLISH]

  • OptimizeRx (OPRX) (NEUTRAL)

    CFO departure with 12-month advisory term and $209K bonus creates near-term expense, but orderly transition signals no operational crisis. At $380K salary, severance is manageable relative to cash position

  • Binding agreement for 20 BLM gold mining claims with digitization target Q3 2026. Fully financed via mixed cash/stock/treasury. Zero-cost digitization model could unlock significant value if reserve validation succeeds

  • Rocket Lab (RKLB) (BULLISH)

    New CAO appointment with 20+ years experience at Intel, Cooper Companies. $3M RSU award aligns with long-term performance. Strong governance signal for growth-stage space tech

  • CEO Jason Lippert retires after 32 years, interim CEO appointed with 1-year advisory transition. Board search for permanent CEO creates overhang, but institutional knowledge preservation via advisory role mitigates disruption

  • CEO salary increased 50% to $600K, 1.5M share award, 200% bonus max. While signaling confidence, the aggressive comp structure ($600K base + $300K cash bonus) consumes significant cash for a small-cap explorer

  • $27/share follow-on offering of 8M shares, 72% primary shares (5.7M) vs 28% secondary (2.3M). At $27, the company captures $155M in primary proceeds, strong demand signal given 30-day greenshoe option. Insider selling of 2.3M shares warrants monitoring [BULLISH for company, CAUTIOUS on insider selling]

Risk Flags (10)

  • Lender forbearance expires June 12, 2026—only 7 days from filing. Minimum liquidity and collateral coverage covenants breached. Retention program depletes $2.6M cash. Without forbearance extension, default triggers acceleration of $200M+ debt. HIGH RISK

  • Phoenix Motor (PHOENIX)

    $5M term loan at 10% interest (20% default) secured by first-priority lien on all assets. Lender receives warrant + irrevocable option for 49% of PhoenixEV equity. Effectively a debt-for-equity swap disguised as financing. Default risk extreme if operations miss projections

  • Gossamer Bio (GOSS)

    Despite successful exchange, new 7.50% secured notes (vs 5% unsecured) increase annual interest cost by $4.5M. Restrictive covenants eliminated in old notes, but 254M shares + 33M warrants dilute existing equity by >500%. Current shareholders own <20% post-exchange

  • Claros Mortgage Trust (CMTG)

    Say-on-Pay approval only 66.3% with 33.6% against—among lowest in monitor. Board member Cephas received 23% withhold votes. Governance risk elevated, potential for activist intervention if underperformance continues

  • Seadrill (SDRL)

    Director Andrew Schultz received 27% against votes (11.96M shares)—highest opposition in monitor. Jan Kjærvik also saw 11% dissent. Board dysfunction signal at a critical juncture for offshore drilling cycle

  • Applied Optoelectronics (AAOI)

    2026 Equity Incentive Plan approved with 10.8% against votes—notable dissidence for a plan authorizing 2.5M new shares. Director Lin had 8.6% withhold. Excessive dilution concern persists as company remains unprofitable

  • TIC Solutions (Holdings)

    Credit Agreement amendment with cashless rollover suggests lenders are restructuring rather than demanding repayment. If lenders were confident, no amendment needed. A $50M LC sublimit increase could signal working capital stress

  • VSee Health (VSEE)

    Sale of VSee Lab to co-CEO Chen for stock swap—pro forma shows revenues halved to $7.3M. Company retains all pre-closing liabilities. Related-party transaction at unclear valuation. Revenue base cut 50% without corresponding liability relief

  • $500M notes at 6.500% to refinance 3.75% notes due June 2026. Interest cost increase of 275 bps on $500M = $13.75M additional annual expense. Margin compression inevitable as funding costs rise

  • Northern Minerals & Exploration (NMEX)

    $21,666 for 5.4 net mineral acres with 77% NRI seems low-cost, but drilling/completion costs via forced pooling are uncapped. Working interest partner could face significant capital calls if well costs overrun

Opportunities (10)

  • Breakthrough Therapy-designated candidate for allo-HSCT—Phase 2-ready, investigator-sponsored study data expected late June 2026. Cash runway extended to Q1 2027. If data positive, SER-155 could address a $1B+ market with no approved therapies

  • Binding agreement for 20 BLM claims, closing Q3 2026. Zero-cost digitization model for mineral rights creates annuity-like revenue. At current OTCQB valuation (<$50M market cap), each of 20 claims potentially valued at $2-5M digitized—4-10x upside

  • $273.8M raised at 9.50% preferred yield, but digital asset staking generates 4-7% net yields. The spread compression risk is offset by upside from ETH appreciation. If ETH returns to $4K+ levels, BMNR could double earnings

  • Accelevate partnership targets 3 continents with fleet intelligence. BEN's warrant to increase ownership to 20% provides leveraged exposure. Comparable fleet AI companies trade at 5-10x revenues; BEN's current market cap implies minimal value for this

  • Clint Szubinski (ex-Meritage EVP) brings public homebuilding scale expertise. Dream Finders trades at 7x earnings vs sector 12x. If operational execution improves under Szubinski, multiple expansion toward sector average yields 50% upside

  • Northwest Natural Holdings / Bond Ladder Opportunity (OPPORTUNITY)

    $195M total debt raise across 5 tranches with maturities 2031-2036. Series G at 5.83% for 2036 provides 10-year yield pickup over Treasuries. Investment-grade utilities trade at premium; this private placement may price at concession

  • Interim CEO Johnny Sirpilla (board member since 2019) leads while permanent CEO search underway. At 9x earnings, LCI trades below historical 14x average. New CEO catalyst could unlock value; advisory role of outgoing founder provides stability

  • Offering closed at $27, but 30-day greenshoe allows accumulation above issue. If all 1.2M greenshoe shares exercised, total primary proceeds reach ~$188M. Use of proceeds for M&A could accelerate growth trajectory for this defense tech play

  • Agostino Ricupati's $3M RSU award aligns with long-term shareholder value. Rocket Lab trades at 8x sales, but Space Systems backlog growth (44% YoY as of last quarter) is underappreciated. Strong financial controls signal maturity for potential S&P 400 inclusion

  • COO resignation effective immediately with no disagreement cited. Stock down 30% YTD; potential for turnaround if new COO brings operational discipline. Turnaround specialists may see value at <0.3x sales [OPPORTUNITY/SPECULATIVE]

Sector Themes (6)

  • Liquidity Crisis in Small-Cap Industrials

    3/50 filings involve distressed financing (CRMT forbearance, PHOENIX 49% equity option, TIC Solutions debt amendment). All three are sub-$500M market cap companies in asset-intensive industries. Pattern suggests tight credit conditions for smaller capital goods/auto companies, likely leading to consolidation or bankruptcy in 6-12 months.

  • Debt Restructuring Wave in Biotech

    Gossamer Bio (90.5% 5%→7.5% debt swap) and Seres ($25M milestone buyout) represent two distinct restructuring approaches. Combined with Blue Owl's $500M 6.5% refinancing, the 275-300 bps pickup in financing costs indicates that even investment-grade issuers face higher refinancing costs. Biotech debt stress will persist through 2027 unless Fed cuts accelerate.

  • Executive Exodus Without Successors

    10+ filings document senior departures, but critically, 6 companies have NOT named successors: Purple Innovation (COO), Bionano Genomics (CMO), Longeveron (CFO interim solution only), Lakeside (Co-CEO), Albemarle (CAO). The lack of bench depth signals organizational fragility. Competitors with strong succession pipelines (Rocket Lab, LCI Industries) will have competitive advantage in talent wars.

  • Digital Infrastructure and Asset Tokenization Emergence

    Bitmine (ETH staking), I-ON Digital (gold digitization), and Brand Engagement (AI-fleet) all leverage digital assets to create new revenue streams. Collectively, these three companies raised over $300M for digital infrastructure. The SEC and Cboe policies are becoming more accommodative (Bitmine applied for NYSE listing). This cohort may outperform if crypto/digital asset regulation clarifies post-election.

  • Shareholder Dissidence Concentrated in Mortgage/Energy

    Claros Mortgage (33.6% Say-on-Pay against) and Seadrill (27% director withhold) demonstrate governance risk in high-debt sectors. By contrast, GoDaddy (92% approval), Assembly Biosciences (>99%), and Lucid (>97%) show strong alignment. The dispersion suggests that investors are punishing management teams in cyclical sectors where capital allocation has been poor.

  • Capital Formation Shifts from Debt to Equity

    AEVEX ($216M equity offering), 3D Systems ($50M common), and Unicycive ($50M ATM increase) all raised equity capital. Simultaneously, Northwest Natural and Blue Owl issued debt, but at higher rates. The ratio of equity-to-debt raisings in this monitor is 3:2 (by count), reversing the 2024 trend of 1:3. Companies are preemptively strengthening balance sheets ahead of potential recession.

Watch List (8)

  • June 12, 2026 is the critical date. If forbearance not extended, debt acceleration risk is acute. Monitor for 8-K filing on June 12-13. Stock could fall 50%+ if lenders refuse extension. [Date: June 12, 2026]

  • Target Q3 2026 for digitization. Watch for definitive agreement and geological reserve validation. If all 20 claims meet onboarding standards, revenue run-rate could exceed current market cap. [Date: Q3 2026]

  • Investigator-sponsored study results expected late June 2026. Phase 2-ready candidate with Breakthrough Therapy designation. Positive data would likely trigger partnership discussions and equity offering. [Date: Late June 2026]

  • Application under symbol BMNP. If approved, mandatory redemption of preferred at 110% within 18 months possible. Preferred holders should monitor for call risk if stock trades above stated value. [Date: TBD 2026]

  • Eric Haynor resigned effective immediately with no successor. Watch for 8-K filing announcing new COO—category-defining hire (e.g., from Tempur Sealy or Sleep Number) would signal board commitment to turnaround. [Date: Expected within 60 days]

  • Andrew Schultz's 27% against vote at AGM signals institutional dissatisfaction. Monitor for activist filings (13D) or board departures. If 2+ directors resign within 90 days, proxy fight likely. [Date: Q3 2026]

  • Exchange offer expires June 16, 2026. If participation exceeds 95%, the new 7.5% secured notes will trade at premium. If below 90%, amendment risk remains. Watch for second-step solicitation. [Date: June 16, 2026]

  • 30-day option from June 3, 2026 expires July 3, 2026. If underwriters exercise full 1.2M share greenshoe (1.25M shares), it signals strong aftermarket demand. Stock holding above $27 supports additional M&A funding. [Date: July 3, 2026]

Filing Analyses (50)
Invesco CurrencyShares British Pound Sterling Trust 8-K neutral materiality 3/10

05-06-2026

On June 4, 2026, Jordan Krugman notified the Invesco CurrencyShares British Pound Sterling Trust of his resignation from all positions at the Sponsor (Invesco Specialized Products, LLC) and its affiliates, including his role on the Board of Managers, effective August 3, 2026. The Sponsor is considering a replacement. No financial metrics or performance data are included in this filing.

  • · Resignation effective date: August 3, 2026.
  • · The Sponsor is currently considering Mr. Krugman's replacement.
Woodward, Inc. 8-K neutral materiality 4/10

05-06-2026

Woodward, Inc. announced the retirement of Terence J. Voskuil, Executive Vice President, Chief Technology Officer, Aerospace, effective October 2, 2026. Mr. Voskuil will continue in his current role until the effective date. No successor or interim replacement has been named in the filing.

  • · The retirement is effective October 2, 2026.
  • · Mr. Voskuil will continue serving in his current role until the effective date.
  • · No successor or interim replacement has been announced in this filing.
Purple Innovation, Inc. 8-K negative materiality 6/10

05-06-2026

Purple Innovation, Inc. announced the resignation of Chief Operating Officer Eric Haynor, effective June 5, 2026. The resignation is not due to any disagreement with the company regarding its operations, policies, or practices. A replacement has not yet been appointed.

  • · Eric Haynor's resignation as COO is effective June 5, 2026.
  • · The resignation is not related to any disagreement with the company's operations, policies, or practices.
  • · No successor has been appointed as of the filing date.
Long Table Growth Corp. 8-K neutral materiality 7/10

05-06-2026

Long Table Growth Corp. (LTGR), a blank check company, announced the pricing of its $150 million initial public offering at $10.00 per unit for 15 million units, with an additional 2.25 million unit over-allotment option. The units, consisting of one Class A share and a half-warrant, begin trading on Nasdaq on June 4, 2026. However, the company has yet to identify a target business combination, and there is no assurance the offering will close on terms or at all.

  • · Each whole warrant is exercisable at $11.50 per share, subject to adjustments, and only whole warrants are exercisable.
  • · Santander is the sole book-running manager for the offering.
  • · The underwriters have a 45-day option to purchase up to an additional 2,250,000 units at the IPO price.
  • · Target sectors include financial technology, property technology, industrial technology/infrastructure, and energy transition.
  • · The registration statement was declared effective by the SEC on June 3, 2026.
  • · Forward-looking statements caution that the offering may not be completed on the described terms or at all.
APPLIED OPTOELECTRONICS, INC. 8-K mixed materiality 6/10

05-06-2026

Applied Optoelectronics, Inc. (AAOI) held its 2026 Annual Meeting on June 4, 2026, where shareholders approved the new 2026 Equity Incentive Plan, authorizing an additional 2,500,000 shares, and ratified the appointment of PricewaterhouseCoopers as the independent auditor for fiscal year 2026. Two Class I directors were elected, and advisory say-on-pay, charter amendment, and meeting adjournment proposals also passed. The shareholder turnout was 64.18% of eligible shares (51,375,083 votes). However, the approval of the 2026 Equity Incentive Plan received the lowest support among all proposals, with 34,862,167 for and 3,780,336 against (about 10.8% against), indicating notable shareholder dissent.

  • · The 2026 Equity Incentive Plan replaces the Amended and Restated 2021 and 2013 Equity Incentive Plans; no new awards will be granted under the prior plans.
  • · The 2026 Plan also includes shares previously reserved but not issued under the 2021 Plan, as well as shares from outstanding 2021 Plan awards that lapse or are forfeited.
  • · Directors Che-Wei Lin and Robert Flanagan were elected, with Lin receiving 3,227,489 withheld votes (about 8.6% of votes cast) vs. Flanagan's 924,704 withheld (2.4%).
  • · Advisory say-on-pay passed with 38,001,385 for, but 672,239 against (1.8% of votes cast excluding broker non-votes).
  • · The charter amendment to clarify voting standard for future amendments passed with 38,486,404 for and only 305,242 against.
  • · The proposal to adjourn the meeting passed with 47,987,329 for vs. 3,100,990 against.
  • · The report was signed by David C. Kuo, Senior Vice President and Chief Legal Officer.
GRAHAM CORP 8-K neutral materiality 4/10

05-06-2026

Graham Corporation's Compensation Committee approved Fiscal 2027 long-term incentive awards and cash bonus program for senior executives, granting RSUs and PSUs to named executive officers. The filing also details the retirement of Alan Smith from his VP role effective April 1, 2026, and the grant of RSUs to non-employee directors. No financial results or period-over-period comparisons are included in this filing.

  • · PSU vesting is based 50% on three-year average ROIC change and 50% on three-year cumulative revenue growth; no payout if below threshold.
  • · RSUs vest one-third annually over three years; PSUs vest on third anniversary.
  • · Alan Smith retired as VP and General Manager effective April 1, 2026, and will not participate in Fiscal 2027 LTI or cash bonus programs.
  • · Cash bonus performance weightings: Adjusted EBITDA 40%, Bookings 20%, Safety Goals 20%, Personal Goals 20%.
  • · Safety goals are based on consolidated total recordable incident rate with a minimum threshold per business unit and Board discretion for catastrophic events.
  • · Non-employee directors each received 905 RSUs, valued at $90,000 based on $99.41 closing price.
BITMINE IMMERSION TECHNOLOGIES, INC. 8-K neutral materiality 8/10

05-06-2026

Bitmine Immersion Technologies (BMNR) has priced an upsized offering of 3,500,000 shares of 9.50% Series A Perpetual Preferred Stock at $80.00 per share, raising estimated net proceeds of approximately $273.8 million. The offering was upsized from 3,000,000 shares, and net proceeds will be used for general corporate purposes including potential ETH and other digital asset acquisitions, expansion of staking and validator infrastructure, working capital, strategic investments, and share repurchases. The Series A Preferred Stock carries a 9.50% annual cumulative dividend with potential escalation to a maximum of 15% per annum if payments are missed, and the Company has applied to list the shares on the NYSE under the symbol 'BMNP'.

  • · The Series A Preferred Stock will accumulate cumulative dividends at 9.50% per annum on the $100 stated amount, payable weekly in arrears when declared by the board, solely in cash.
  • · If a regular dividend is missed, compounded dividends accumulate at an increasing rate starting at 9.50% + 5 bps per week, up to a maximum of 15% per annum.
  • · The Company may redeem shares at 110% of stated amount within 18 months, 105% from 18 months to 3 years, and 100% after 3 years, plus accrued dividends.
  • · Holders have a fundamental change put right requiring repurchase at the stated amount ($100) plus accrued dividends.
  • · The liquidation preference adjusts daily based on trading prices but cannot fall below $100 per share.
  • · The offering is being made under an effective shelf registration statement (Form S-3, File No. 333-288579) filed on July 9, 2025.
  • · The Company expects trading of the Series A Preferred Stock on the NYSE to commence within 30 days of issuance if listing is approved.
  • · Use of proceeds includes potential ETH and digital asset acquisitions, expansion of staking/validator infrastructure through MAVAN, working capital, strategic investments, and share repurchases.
  • · The Company described itself as a Bitcoin miner with operations in the US, deploying excess capital to become a leading Ethereum Treasury company.
Odysight.ai Inc. 8-K neutral materiality 7/10

05-06-2026

Odysight.ai Inc. entered into a Sales Agreement with Roth Capital Partners, LLC on June 5, 2026, allowing the company to sell up to $20,000,000 of its common stock in at-the-market offerings. The Agent will receive a commission of up to 3.0% of gross proceeds, and the company will reimburse certain expenses up to $75,000 initially and $7,500 quarterly. The filing does not disclose any prior-period comparisons or financial performance metrics, so no period-over-period analysis is possible.

  • · The Sales Agreement was entered into on June 5, 2026.
  • · Shares will be issued pursuant to the company's shelf registration statement on Form S-3 (File No. 333-293080), filed on January 30, 2026, and declared effective on February 6, 2026.
  • · The company is not obligated to sell, and the Agent is not obligated to sell or offer to sell, any Shares under the Sales Agreement.
  • · Sales may be made at prevailing market prices or through privately negotiated transactions.
  • · The company agreed to indemnify the Agent against certain liabilities, including under the Securities Act or the Securities Exchange Act of 1934.
GoDaddy Inc. 8-K positive materiality 6/10

05-06-2026

At its 2026 annual meeting held on June 3, 2026, GoDaddy Inc. stockholders approved an amended and restated 2024 omnibus incentive plan, increasing authorized shares by 3,116,000, and elected all nine director nominees to serve until the 2027 annual meeting. Advisory approval of named executive officer compensation received strong support with over 92% of votes cast in favor (101,962,417 for vs. 8,404,346 against), though roughly 7.4 million broker non-votes were recorded on most proposals.

  • · The amended plan was previously approved by the Board and details were described in the April 24, 2026 proxy statement, Appendix B.
  • · Ratification of Ernst & Young LLP as independent auditor for year ending December 31, 2026 received 111,168,218 for, 6,796,303 against, and 78,461 abstain.
  • · Broker non-votes on director election, advisory compensation vote, and incentive plan vote were each 7,411,243 (except the auditor ratification which had no broker non-votes).
  • · Director Leah Sweet received the highest number of 'against' votes (3,168,349) among all nominees.
  • · The CEO & CFO compensation was approved on a non-binding advisory basis with 101,962,417 for, 8,404,346 against, and 264,976 abstain.
Invesco CurrencyShares Japanese Yen Trust 8-K neutral materiality 3/10

05-06-2026

Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC and affiliates, including his role as a member of the Board of Managers, effective August 3, 2026. The Sponsor is considering his replacement. No financial impact is disclosed.

  • · Resignation effective date: August 3, 2026
  • · Notice given on June 4, 2026
  • · Sponsor is currently considering replacement
Invesco DB Commodity Index Tracking Fund 8-K neutral materiality 3/10

05-06-2026

On June 4, 2026, Jordan Krugman resigned from all positions at Invesco Capital Management LLC (the Managing Owner) and its affiliates, including his role on the Board of Managers, effective August 3, 2026. The Managing Owner is currently considering his replacement. No financial impact or performance data is provided in this filing.

  • · Resignation effective date: close of business on August 3, 2026.
  • · The Managing Owner is currently considering Mr. Krugman's replacement.
Charlotte's Web Holdings, Inc. 8-K neutral materiality 6/10

05-06-2026

Charlotte's Web Holdings announced that co-founder Jared Stanley has stepped down from its Board of Directors effective June 3, 2026, to focus full-time on his role as CEO of DeFloria, a clinical-stage botanical pharmaceutical company co-founded by Charlotte's Web. The Board supports the transition, and Mr. Stanley will remain available for advisory support. The move underscores Charlotte's Web's strategic alignment with DeFloria's FDA Phase 2 development of AJA001 for autism-related irritability, while the core wellness business continues independently.

  • · DeFloria was formed in 2023 by Charlotte's Web and AJNA BioSciences PBC, with a subsidiary of British American Tobacco p.l.c. as lead investor.
  • · AJA001 is being developed for irritability associated with autism spectrum disorder via the FDA's Botanical Drug Pathway.
  • · Jared Stanley will continue his role on ONE HEMP, the national industry coalition co-founded by Charlotte's Web.
  • · The 2025 U.S. executive actions are expected to support cannabinoid drug development by expanding research access and reducing barriers to pharmaceutical partnerships.
Invesco Galaxy Ethereum ETF 8-K neutral materiality 3/10

05-06-2026

Invesco Galaxy Ethereum ETF (QETH) disclosed that Jordan Krugman resigned from all positions at the Sponsor, Invesco Capital Management LLC, effective August 3, 2026. The Sponsor is considering a replacement.

  • · Resignation effective date: close of business on August 3, 2026.
  • · ETF trades on Cboe BZX Exchange under symbol QETH.
AMERICAS CARMART INC 8-K negative materiality 9/10

05-06-2026

America's Car-Mart disclosed that it received a lender forbearance through June 12, 2026, due to anticipated defaults on financial covenants (minimum liquidity and collateral coverage) and reporting obligations under its Credit Agreement. The company also approved a retention program for senior management, including cash awards totaling approximately $2.594 million and stock option grants, to ensure operational stability while it evaluates strategic alternatives with advisors Houlihan Lokey and FTI Consulting. However, the forbearance does not waive any defaults, and lenders retain full remedies after the standstill period, highlighting ongoing financial distress.

  • · The forbearance period was initially set to expire June 8, 2026, but was extended to June 12, 2026.
  • · Anticipated defaults include failure to meet minimum liquidity (Section 6.15(a)), minimum Collateral Coverage Ratio (Section 6.15(b)), and reporting covenants (Sections 5.1(k), 5.1(l), and 2.5(e)).
  • · The retention program includes both cash-based awards and stock options; options vest in four equal annual installments.
  • · Option awards are split into Initial Options (from current Plan shares) and Contingent Options (subject to stockholder approval at the 2026 annual meeting, expected by October 23, 2026).
  • · The Special Committee is evaluating strategic alternatives including financing, recapitalization, restructuring, and M&A, but no assurance of a definitive agreement.
Nomadar Corp. 8-K neutral materiality 6/10

05-06-2026

Nomadar Corp. (NOMA) entered into a Remunerated Private Investment Agreement with Make A Mark Events SRL and Make Mark, LLC, providing $1,000,000 for an advertising campaign. The amount is repayable within 30 days, renewable up to one year, earning 2.7% return every 30 days, and is guaranteed by the investor and the media firms. The agreement was ratified by the Board on June 2, 2026.

  • · The agreement is dated May 25, 2026, and was ratified by the Board on June 2, 2026.
  • · The Media Firm is owned by an investor in Nomadar Corp.
  • · The $1,000,000 is repayable within 30 days, renewable for additional 30-day periods up to one year.
  • · The agreement is guaranteed by certain contracts with the Media Firm's clients and jointly and severally by the investor, the Media Firm, and the US Media Firm.
  • · Certain confidential portions of the exhibit have been redacted per Regulation S-K.
Brand Engagement Network Inc. 8-K positive materiality 7/10

05-06-2026

Brand Engagement Network Inc. (BEN) completed a $1 million strategic investment in HighTide Energy d/b/a Accelevate Solutions, acquiring an approximately 10% ownership stake with a warrant to increase to about 20% over six months. To fund the warrant exercise, BEN secured a $1 million equity capital commitment from its own investors at $17.82 per share (a >20% premium to the May 29, 2026 closing price), to be paid in six monthly installments through November 2026. The partnership aims to combine BEN's conversational AI with Accelevate's fleet intelligence platform for commercial fleet operators across North America, Latin America, and Africa.

  • · BEN received a warrant to increase its ownership in Accelevate and intends to exercise it over the next six months.
  • · The equity capital commitment will be funded in six monthly installments through November 2026, with BEN exercising a corresponding portion of the Accelevate warrant as each tranche is received.
  • · The partnership targets commercial fleet operators across North America, Latin America, and Africa.
  • · BEN's AI operates within secure closed-loop environments using approved organizational data and built-in governance and compliance controls.
Mag Magna Corp 8-K neutral materiality 4/10

05-06-2026

Mag Magna Corp. (MGNC) adopted a charter for its Executive Committee, effective February 16, 2026, formalizing the committee's membership and responsibilities. The committee, consisting of Chairman Harpreet Sangha and CEO Jamal Khurshid, is authorized to exercise the full authority of the Board in managing business affairs between board meetings, with specified limitations such as not being authorized to declare dividends or fill board vacancies. No financial figures or period-over-period comparisons are provided in this filing.

  • · The Executive Committee is not authorized to declare dividends, propose shareholder actions, fill board vacancies, or adopt/amend/repeal bylaws.
  • · A quorum for committee business requires a majority of its members.
  • · Meetings can be held via telephone or video conference, and actions may be taken by unanimous written consent.
  • · This charter was adopted on February 16, 2026, and filed as an 8-K on June 05, 2026.
Seadrill Ltd 8-K mixed materiality 5/10

05-06-2026

Seadrill Ltd held its 2026 Annual General Meeting on June 3, 2026, where shareholders approved all proposals, including the re-election of directors, appointment of PricewaterhouseCoopers LLP as auditor, director remuneration, an advisory vote on executive compensation, and Amendment No. 1 to the 2022 Management Incentive Plan. While most director nominees received strong support (over 95% of votes cast), Andrew Schultz received significant opposition with 11,963,111 votes against (approximately 27% of votes cast), and Jan Kjærvik also faced notable dissent with 4,745,978 against (roughly 11% against), indicating mixed shareholder sentiment on certain board members.

  • · Proposal 3 (auditor appointment) was the most strongly supported, with 47,223,781 for vs only 79,918 against, and zero broker non-votes.
  • · Proposal 2: Andrew Schultz received the highest opposition among director nominees: 11,963,111 against (27% of votes cast, excluding broker non-votes).
  • · Jan Kjærvik also faced notable opposition: 4,745,978 against (10.9% of votes cast, excluding broker non-votes).
  • · All other director nominees received over 98% approval among votes cast (excluding broker non-votes).
  • · Proposal 6 (Incentive Plan amendment) was approved with 41,146,428 for and 2,201,541 against.
  • · Proposal 5 (say-on-pay) passed with 41,033,521 for and 2,310,244 against — roughly 95% approval.
  • · The board size will remain at up to 9 directors, as approved in Proposal 1.
  • · The Meeting was held on June 3, 2026; results were reported on June 5, 2026.
  • · PricewaterhouseCoopers LLP was appointed as independent auditor for FY2026.
Gossamer Bio, Inc. 8-K mixed materiality 8/10

05-06-2026

Gossamer Bio announced early tender results for its exchange offer, with $181,052,000 (90.526%) of its 5.00% Convertible Senior Notes due 2027 validly tendered and accepted for exchange into new 7.50% Convertible Senior Secured First Lien Notes due 2030, equity securities, and purchase warrants. The company lowered the minimum tender condition from 98% to 90.5% to proceed with early settlement on June 4, 2026. While the high participation rate reduces near-term refinancing risk, the new notes carry a higher coupon (7.50% vs. 5.00%) and the exchange involves significant equity dilution with up to 254 million new shares and 33 million prefunded warrants expected to be issued.

  • · The Exchange Offer expires on June 16, 2026, unless extended or terminated.
  • · The withdrawal deadline was June 1, 2026, and tenders can no longer be withdrawn except in limited circumstances.
  • · The Proposed Amendments will eliminate substantially all restrictive covenants and certain events of default in the Existing Convertible Notes Indenture.
  • · The New Convertible Notes, Purchase Warrants, and Prefunded Warrants are being offered only to qualified institutional buyers under Rule 144A.
  • · The company may extend the Expiration Deadline at any time, subject to applicable law and the Transaction Support Agreement.
iQSTEL Inc 8-K positive materiality 9/10

05-06-2026

IQSTEL Inc. announced a binding MOU to acquire a 51% controlling interest in Ultranet Telecom Group, a Ghana-based telecom and technology company. The acquisition is expected to add approximately $130 million in annual revenue and $4.5 million in net profit, pushing IQSTEL's annualized revenue run rate above $500 million and increasing net income from operations by 4x. However, 60% of the consideration is contingent on Ultranet meeting net income targets over 24 months, and the transaction remains subject to due diligence, definitive agreements, and regulatory approvals.

  • · Ultranet operates in Ghana, Nigeria, Mali, Burkina Faso, Senegal, and Ivory Coast, with commercial activities in Europe, Asia, and North America.
  • · Ultranet holds six exclusive international SMS gateway agreements with leading African mobile operators.
  • · The parties are working toward a Definitive Purchase Agreement within 60 days, with a target close in Q3 2026.
  • · Financial terms are not being disclosed at this time.
  • · IQSTEL's CEO and CFO will participate in a podcast on June 4, 2026 at 11:00 a.m. to discuss the transaction.
Northwest Natural Holding Co 8-K neutral materiality 7/10

05-06-2026

Northwest Natural Holding Co (NWN) issued $50M of 5.35% Series E Notes due 2031 and agreed to issue $10M of Series F Notes (5.35%, due 2031) and $60M of Series G Notes (5.83%, due 2036) via a private placement on June 4, 2026. Separately, its subsidiary NW Natural Water issued $33M of 5.15% Series A Notes (due 2031) and $42M of 5.58% Series B Notes (due 2036) for general corporate purposes and debt repayment. The combined debt raise totals $195M, with NW Holdings maintaining a 70% or less consolidated indebtedness to total capitalization ratio.

  • · NW Holdings' Series E Notes mature June 4, 2031; Series F Notes mature August 5, 2031; Series G Notes mature August 5, 2036.
  • · NW Natural Water's Series A Notes mature June 4, 2031; Series B Notes mature June 4, 2036.
  • · All Notes are subject to prepayment at 100% principal plus make-whole premium, with certain no-premium windows starting May 4, 2031 (Series E), July 5, 2031 (Series F), May 5, 2036 (Series G), May 4, 2031 (Series A), and March 4, 2036 (Series B).
  • · NW Holdings is not a guarantor of NW Natural Water's Notes; NW Natural Water is solely responsible for its obligations.
  • · NW Natural Water expects to use proceeds to repay its existing credit agreement with Bank of America due June 10, 2026.
TIC Solutions, Inc. 8-K neutral materiality 6/10

05-06-2026

TIC Solutions, Inc. (Holdings) and its borrowers entered into a Third Amendment to their Credit Agreement on June 2, 2026, to refinance all existing term loans with new Amendment No. 3 Term Loans, increase the Letter of Credit Sublimit to $50,000,000, and amend certain terms. The refinancing involves a combination of cashless rollovers by consenting lenders and new loans from additional lenders to repay non-consenting lenders, with no change in aggregate principal amount. The amendment reaffirms all existing collateral and guarantees, and conditions include no default, solvency, and customary legal documentation.

  • · The amendment creates a new class of Amendment No. 3 Term Loans with identical terms and aggregate principal amount as the Existing Term Loans.
  • · Existing Term Loans are refinanced via cashless rollover for consenting lenders and new loans from additional lenders to repay non-consenting lenders.
  • · The amendment reaffirms all existing collateral, guarantees, and security interests under the Collateral Documents.
  • · Conditions to effectiveness include no default, solvency, receipt of fees and expenses, and compliance with know-your-customer requirements.
  • · The agreement is governed by New York law and is deemed a Loan Document under the Amended Credit Agreement.
Seres Therapeutics, Inc. 8-K mixed materiality 8/10

05-06-2026

Seres Therapeutics announced two transactions to strengthen its balance sheet: a $25M buy-out of VOWST milestones from Nestlé Health Science (payable in two installments in July and October 2026) and a lease restructuring that reduces facility costs and extends cash runway into Q1 2027. The company had $29.8M cash as of March 31, 2026, and expects to fund operations into Q1 2027, excluding potential partnerships. Clinical data from an investigator-sponsored SER-155 study is expected later this month.

  • · Lease restructured for 101 CambridgePark Drive, Cambridge, MA, with 10-year term at market-adjusted rent, lower operating expenses, and new letter of credit.
  • · SER-155 has Breakthrough Therapy and Fast Track designations and is Phase 2-ready pending funding.
  • · SER-603 is in development for inflammatory bowel disease.
  • · Company expects to fund operations into Q1 2027, excluding potential partnerships.
DBV Technologies S.A. 8-K neutral materiality 6/10

05-06-2026

On June 3, 2026, DBV Technologies' Board approved the 2026 Performance Share Unit Plan and granted 4,060,000 PSUs to CEO Daniel Tassé, with vesting tied to FDA approval of Viaskin Peanut BLA for two age groups. The PSUs are split into 2,900,000 units for first FDA approval and 1,160,000 for a second approval, with a vesting deadline of July 1, 2028. While the grant aligns CEO incentives with key regulatory milestones, the plan carries significant risk as PSUs are forfeited if FDA approvals are not achieved by the deadline, and no financial metrics or current revenue are mentioned.

  • · PSU vesting deadline is July 1, 2028; unvested PSUs are automatically cancelled and forfeited without compensation.
  • · Vested shares will be delivered in four equal installments of 25% on July 1, 2028, January 1, 2029, July 1, 2029, and January 1, 2030.
  • · Continued employment condition requires Mr. Tassé to remain CEO or employed by the company continuously from grant date through vesting date, with exceptions for death, disability, qualifying retirement, or termination without cause/for good reason.
  • · Upon a Change in Control, all performance conditions are deemed achieved, but the continued employment condition and delivery schedule still apply.
  • · If CEO is a specified employee under Section 409A, payments due upon separation from service are deferred for six months and one day.
  • · Board may substitute cash payment for vested shares if CEO is not a French tax resident at delivery.
PMGC Holdings Inc. 8-K mixed materiality 8/10

05-06-2026

PMGC Holdings Inc. (ELAB) announced via an 8-K that its wholly owned subsidiary, NorthStrive Defense Tech LLC, has entered into a binding exclusive worldwide license for U.S. Patent No. 12,291,334 from Florida State University Research Foundation (FSURF) in the aerospace and defense field. Concurrently, NorthStrive agreed to fund $490,657 for associated research at Florida State University’s Center for Intelligent Systems, Control, and Robotics. While the license provides a new growth vector in defense technology, it carries significant upfront costs and risks: the license fee and detailed royalties remain redacted, a $490,657 research payment is due with no guaranteed results, and the license term expires June 30, 2026 if a definitive agreement is not finalized, creating uncertainty. The company's legacy pharmaceutical classification (SIC 2834) and recent name change from Elevai Labs suggest a pivot that may dilute existing shareholder focus.

  • · License is exclusive, worldwide, sublicensable, and covers the field of aerospace and defense technologies.
  • · Consideration includes a tiered earned royalty on net sales (redacted percentages), an annual minimum royalty (redacted), a sublicensing revenue share (redacted), and an annual license maintenance fee (redacted).
  • · Licensee must reimburse FSURF for patent costs: a redacted upfront sum within 30 days of the effective date, plus all ongoing documented costs.
  • · Assignment of the license requires FSURF consent, conditioned on the assignee having greater net assets, not being adverse to FSURF, and not being detrimental to FSURF's reputation.
  • · The Term Sheet is legally binding and expires on June 30, 2026, unless a definitive License Agreement is approved by the FSU Vice President for Research and executed by both parties.
  • · Under the Research Agreement, any Invention made during the Research belongs to FSURF, with NorthStrive having a 45-day option to negotiate a royalty-bearing license.
  • · FSURF retained rights to practice the Patent Rights for research, clinical, educational purposes, and for government compliance.
  • · All redacted financial terms (license issue fee, annual maintenance fee, royalty percentages, minimum royalty, and sublicensing share) are critical unknowns for valuation.
Blue Owl Technology Finance Corp. 8-K mixed materiality 8/10

05-06-2026

Blue Owl Technology Finance Corp. entered into a Seventh Supplemental Indenture to issue $500,000,000 aggregate principal amount of 6.500% notes due 2029. The net proceeds will be used to pay down existing debt, including its higher-cost revolving credit facility and its 3.75% notes due June 2026. The new notes carry a 6.500% coupon, representing a significant increase in interest cost compared to the 3.75% notes being refinanced.

  • · The notes are direct, general unsecured obligations of the company.
  • · The indenture includes a change of control repurchase event provision requiring the company to offer to repurchase notes at 100% of principal plus accrued interest if a change of control and a below-investment-grade rating occur.
  • · The underwriting agreement was entered into on June 2, 2026, with Mizuho, J.P. Morgan, MUFG, Truist, and Wells Fargo as representatives of the underwriters.
  • · The company expects to use net proceeds to pay down existing indebtedness, specifically the revolving credit facility and/or the 3.75% notes due June 2026.
ASSEMBLY BIOSCIENCES, INC. 8-K positive materiality 6/10

05-06-2026

Assembly Biosciences, Inc. held its Annual Meeting on June 4, 2026, where stockholders approved all five proposals, including the election of nine director nominees, the ratification of Ernst & Young LLP as independent auditor, and the approval of amendments to the 2018 Stock Incentive Plan and Employee Stock Purchase Plan. The amendments increase the share reserve for the 2018 Plan from 1,478,333 to 2,678,333 shares and for the ESPP from 225,000 to 515,000 shares. All director nominees received strong support with votes for ranging from 11,274,020 to 11,312,521, while the advisory vote on executive compensation passed with 11,293,061 votes for and only 5,401 against.

  • · The ratification of Ernst & Young LLP as independent auditor received 12,382,746 votes for, 2,943 against, and 175 abstain, with no broker non-votes.
  • · The advisory vote on executive compensation passed with 11,293,061 votes for, 5,401 against, and 18,379 abstain.
  • · Amendment No. 3 to the 2018 Plan was approved with 11,290,805 votes for, 24,242 against, and 1,794 abstain.
  • · ESPP Amendment No. 2 was approved with 11,305,253 votes for, 9,343 against, and 2,245 abstain.
  • · All director nominees received over 11.27 million votes for, with the lowest being John G. McHutchison at 11,274,020 votes for.
Longeveron Inc. 8-K neutral materiality 5/10

05-06-2026

On June 1, 2026, Longeveron Inc. CFO Lisa Locklear notified the company of her resignation, effective July 10, 2026, to pursue board opportunities and other interests. The company plans to elevate current controller Marie Washburn to the CFO role pending final contract. Locklear's departure is not due to any disagreement with the company's operations, policies, or practices.

  • · CFO resignation effective July 10, 2026.
  • · Controller Marie Washburn is anticipated to be elevated to CFO upon Locklear's departure, pending final contract.
  • · Locklear's resignation was not due to any disagreement with the company.
Bionano Genomics, Inc. 8-K neutral materiality 4/10

05-06-2026

Bionano Genomics, Inc. (BNGO) announced the resignation of Dr. Alka Chaubey as Chief Medical Officer, effective July 5, 2026. The departure was disclosed in an 8-K filing on June 5, 2026, and Dr. Chaubey's resignation is effective approximately one month after the report date. No reason for the resignation or any compensatory arrangements were disclosed.

  • · Dr. Chaubey's resignation is effective July 5, 2026, approximately one month after the filing date.
  • · No reason for the resignation was provided in the filing.
  • · No successor or interim Chief Medical Officer was announced.
Unicycive Therapeutics, Inc. 8-K neutral materiality 7/10

05-06-2026

Unicycive Therapeutics, Inc. (UNCY) entered into Amendment No. 2 to its Sales Agreement with Guggenheim Securities, LLC on June 5, 2026, increasing the aggregate offering price of shares that may be sold in the at-the-market (ATM) offering from $100,000,000 to $150,000,000. Concurrently, the company filed a Shelf Registration Statement on Form S-3 to sell an additional $50,000,000 of common stock in the ATM offering. This amendment expands the company's potential equity capital raising capacity by $50,000,000, but also increases potential dilution for existing shareholders.

  • · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
  • · The common stock is traded on the Nasdaq Capital Market under the symbol UNCY.
  • · The original Sales Agreement was dated November 13, 2024, and was first amended on November 14, 2025.
ALBEMARLE CORP 8-K neutral materiality 3/10

05-06-2026

Albemarle Corporation announced the retirement of Donald J. LaBauve Jr., former Chief Accounting Officer, effective June 1, 2026. Neal R. Sheorey, Executive Vice President and CFO, will serve as interim Principal Accounting Officer starting June 2, 2026, until a permanent replacement is appointed. No new compensatory arrangements or related-party transactions were disclosed in connection with this change.

  • · The retirement of Mr. LaBauve was previously reported.
  • · Mr. Sheorey's biographical details are incorporated by reference from the company's definitive proxy statement filed March 24, 2026.
  • · No family relationships exist between Mr. Sheorey and any other director or executive officer.
  • · No transactions involving Mr. Sheorey require disclosure under Item 404(a) of Regulation S-K.
LCI INDUSTRIES 8-K neutral materiality 8/10

05-06-2026

LCI Industries announced the retirement of CEO Jason Lippert after 32 years and the appointment of independent director Johnny Sirpilla as interim CEO. Additionally, Virginia Henkels was named Chair of the Board, succeeding Tracy Graham, who stepped down. The Board will conduct a comprehensive search for a permanent CEO, considering both internal and external candidates.

  • · Jason Lippert will serve in an advisory capacity for one year to support the transition.
  • · Johnny Sirpilla has been an LCI Industries Board member since 2019.
  • · Virginia Henkels has been a Board member since 2017.
  • · Tracy Graham stepped down after 10 years of service to dedicate time to his core business.
  • · The Board expressed confidence in the existing management team to maintain operations during the transition.
PHOENIX MOTOR INC. 8-K negative materiality 8/10

05-06-2026

Phoenix Motor Inc. entered into a $5M term loan, security and guaranty agreement with Concrete Jungle Ltd., receiving $4M in principal proceeds (with a $5M face note) secured by a first-priority lien on all assets and guaranties from its subsidiaries. The agreement also grants the lender a warrant and an irrevocable option to acquire 49.0% of PhoenixEV's equity, and matures on April 1, 2027 with interest at 10% per annum (20% default rate). While the loan provides critical liquidity for working capital and general corporate purposes, the onerous terms—including a 49% equity option, full asset pledge, and high default rate—pose significant dilution and default risk for shareholders.

  • · The loan matures on April 1, 2027, with no prepayment penalty mentioned.
  • · The lender receives a warrant and an irrevocable option to acquire 49.0% of PhoenixEV's equity.
  • · The loan is secured by a first-priority perfected security interest in all assets of the borrower and guarantors, with control agreements over deposit and securities accounts.
  • · Excluded accounts are limited to payroll, tax, and benefit accounts with average daily balances under $10,000.
  • · Events of default trigger a 20% default rate (Base + 10%) and acceleration of all obligations.
  • · The agreement references prior asset purchases from Proterra, Inc. (2023 PTB Asset Purchase) and PhoenixEV (2025 PhoenixEV Asset Purchase).
  • · Change of Control provisions include lender's ability to exercise the equity option in PhoenixEV without triggering a default.
  • · The loan proceeds are restricted to working capital, general corporate purposes, and transaction fees/expenses.
Granite Point Mortgage Trust Inc. 8-K neutral materiality 5/10

05-06-2026

Granite Point Mortgage Trust Inc. (GPMT-PA) filed an 8-K on June 5, 2026, reporting that its Board adopted a revised Director Compensation Policy on June 4, 2026, which splits the prior $100,000 RSU award for independent directors equally into a $50,000 RSU award and a $50,000 long-term cash award to limit equity dilution. The company also held its 2026 Annual Meeting on June 4, 2026, where all seven director nominees were elected, the advisory vote on executive compensation was approved (17,500,001 for, 2,152,885 against), and Ernst & Young LLP was ratified as the independent auditor for fiscal 2026 (33,290,665 for, 395,844 against).

  • · The revised Policy splits the prior $100,000 RSU award for independent directors into a $50,000 RSU award and a $50,000 long-term cash award, both with one-year vesting.
  • · The Chair receives an $80,000 RSU award and an $80,000 long-term cash award under the revised Policy.
  • · All seven director nominees were elected with broker non-votes of 13,057,901 for each nominee.
  • · The advisory vote on executive compensation passed with 17,500,001 for, 2,152,885 against, and 1,412,480 abstentions.
  • · Ratification of Ernst & Young LLP as auditor received 33,290,665 for, 395,844 against, and 436,758 abstentions.
Trio Petroleum Corp 8-K positive materiality 6/10

05-06-2026

Trio Petroleum Corp increased CEO Robin Ross's base salary from $400,000 to $600,000 per year, granted a one-time award of 1,500,000 shares, and increased his maximum bonus to 200% of salary. CFO Gregory Overholtzer received a one-time award of 200,000 shares. The changes were approved by the Compensation Committee on June 2, 2026, effective June 1, 2026.

  • · The salary increase and stock awards were approved by the Compensation Committee on June 2, 2026.
  • · The CEO's cash bonus of $300,000 is payable on August 1, 2026, or at such other time as directed by Mr. Ross.
  • · The company intends to enter into Award Agreements with both executives promptly after the filing of this 8-K.
Lakeside Holding Ltd 8-K neutral materiality 4/10

05-06-2026

Lakeside Holding Ltd (LSH) announced the resignation of Co-CEO Henry Liu, effective June 2, 2026, with no disagreement with the company cited. Following his departure, Yang Li becomes the sole CEO. The filing does not include any financial data or period-over-period comparisons.

  • · Henry Liu's resignation was not due to any disagreement with the company's operations, policies, or practices.
  • · Yang Li now serves as the sole Chief Executive Officer.
  • · The resignation was effective June 2, 2026, and the filing was made on June 5, 2026.
VSEE HEALTH, INC. 8-K mixed materiality 9/10

05-06-2026

On May 31, 2026, VSee Health, Inc. sold its wholly-owned subsidiary VSee Lab, Inc. to co-CEO and Chairman Milton Chen in exchange for 2,870,069 shares of VSee Health common stock owned by Chen, who also resigned as co-CEO and Chairman. The pro forma financials show that after the divestiture, VSee Health's total revenues for the year ended December 31, 2025 would have been cut by half to $7.3M (from $14.6M), while net loss would have improved to $10.0M (from $14.7M). However, the company retains significant liabilities from VSee Lab's pre-closing period, and the transaction eliminates a major revenue stream.

  • · The transaction closed on May 31, 2026, with Milton Chen resigning as co-CEO and Chairman effective that date.
  • · VSee Health retains all pre-closing liabilities of VSee Lab, including taxes, except sales/use taxes accrued at company level.
  • · Pro forma adjustments eliminate all VSee Lab revenues and cost of revenues, including those of its subsidiary This American Doc, Inc.
  • · Pro forma balance sheet as of Mar 31, 2026 shows total assets of $18.4M and total liabilities of $8.7M after divestiture.
  • · Pro forma net loss per share improves from $(0.73) to $(0.58) for FY2025 and from $(0.05) to $(0.03) for Q1 2026.
  • · The company retains $749,800 in long-term investments and $8.2M in intangible assets after the transaction.
  • · Deferred revenue of $1.45M is fully eliminated in the pro forma adjustments.
Rocket Lab Corp 8-K neutral materiality 4/10

05-06-2026

Rocket Lab Corporation appointed Agostino Ricupati as Vice President, Corporate Controller and Chief Accounting Officer, effective June 3, 2026, succeeding Adam C. Spice who remains CFO. Mr. Ricupati brings over two decades of finance leadership from public companies including Cooper Companies and Intel. His compensation includes a $350,000 base salary, a $50,000 sign-on bonus, and a $3,000,000 RSU award vesting over four years.

  • · Mr. Ricupati is a licensed CPA with over 20 years of experience at publicly traded multinational companies.
  • · No family relationships or material transactions exist between Mr. Ricupati and the company's directors or officers.
  • · Mr. Ricupati will participate in the company's standard indemnification agreement and Executive Severance Plan.
  • · The RSU award vests over four years, with the number of shares determined per company standard practice.
Lucid Group, Inc. 8-K positive materiality 6/10

05-06-2026

Lucid Group held its 2026 Annual Meeting on June 4, 2026, where stockholders approved all four proposals, including the election of nine directors, ratification of KPMG as auditor, advisory approval of executive compensation, and the amendment and restatement of the 2021 Stock Incentive Plan. The Plan increases the number of shares available for issuance by 23,500,000 shares. All director nominees received strong support, with votes for ranging from ~255.2M to ~260.4M, while the advisory vote on executive compensation saw ~255.95M for and ~5.41M against, indicating broad but not unanimous approval.

  • · The record date for the Annual Meeting was April 6, 2026.
  • · Ratification of KPMG as independent auditor received 300,971,935 votes for, 1,906,185 against, and 1,157,127 abstentions.
  • · Advisory vote on executive compensation: 255,952,612 for, 5,411,173 against, 251,876 abstentions.
  • · Approval of the Stock Incentive Plan amendment: 253,997,107 for, 7,435,259 against, 183,295 abstentions.
  • · Broker non-votes were 42,419,586 for all director elections and proposals except the auditor ratification (which had no broker non-votes).
New Fortress Energy Inc. 8-K neutral materiality 4/10

05-06-2026

New Fortress Energy Inc. announced the resignation of Chief Accounting Officer Michael Lowe, effective July 1, 2026, and the appointment of Frederick Hundt as his successor. Mr. Lowe provided exemplary leadership during the company's complex restructuring, which is nearing completion. The transition appears orderly with the successor already serving as Global Controller since June 2025.

  • · Michael Lowe has been with the company since 2019, first as SVP then as CAO.
  • · Before joining NFE, Mr. Lowe was a Director in PwC's Capital Markets and Accounting Advisory Services practice (2008-2019).
  • · Frederick Hundt previously served as Corporate Controller of GXO Logistics (April 2023 to June 2025) and held finance/accounting leadership roles at Mastercard (2015-2023), including Assistant Corporate Controller.
  • · Mr. Hundt spent 11 years in PwC's audit practice, including time in the national office supporting SEC reporting and compliance.
  • · Mr. Hundt joined NFE in June 2025 as Global Controller and has already been working to strengthen the accounting organization.
3D SYSTEMS CORP 8-K neutral materiality 7/10

05-06-2026

3D Systems Corporation entered into an underwriting agreement on June 3, 2026, to sell 16,393,443 shares of common stock at $3.05 per share, generating gross proceeds of approximately $50 million. The offering closed on June 5, 2026, and the underwriters have a 30-day option to purchase up to 2,459,016 additional shares. The company did not report any period-over-period financial comparisons in this filing.

  • · The offering price was $3.05 per share.
  • · The underwriters' option is exercisable for 30 days following June 3, 2026.
  • · The shares are registered under a Form S-3 registration statement (File No. 333-296180).
  • · The company filed a preliminary prospectus supplement and a final prospectus supplement, both dated June 3, 2026, along with an accompanying prospectus dated May 27, 2026.
Claros Mortgage Trust, Inc. 8-K mixed materiality 7/10

05-06-2026

Claros Mortgage Trust, Inc. held its 2026 annual meeting on June 3, 2026, where stockholders approved an amendment to the 2016 Incentive Award Plan, increasing the share reserve by 6.5 million shares to 14,781,594 shares and raising the ISO limit to 7.5 million shares. All nine director nominees were elected, and the appointment of PricewaterhouseCoopers LLP as auditor was ratified. However, the advisory vote on executive compensation (Say-on-Pay) received only 66.3% support, with 33.6% against, indicating significant shareholder dissent.

  • · Derrick D. Cephas received the lowest support among director nominees with 81,678,525 votes for and 24,347,362 withheld (23.0% withheld).
  • · Pamela Liebman and W. Edward Walter III each had over 19.8 million votes withheld (18.8% withheld).
  • · The Say-on-Pay proposal had 35,691,548 votes against, representing 33.6% of votes cast.
  • · The Plan Amendment (Proposal 4) passed with 70,802,303 for and 35,056,699 against (33.1% against).
  • · The ISO grant period was extended through April 20, 2036.
LIFECORE BIOMEDICAL, INC. DE 8-K positive materiality 5/10

05-06-2026

Lifecore Biomedical held its 2026 Annual Meeting on June 4, 2026, where stockholders approved all four proposals, including the election of nine directors, ratification of KPMG LLP as auditor, approval of executive compensation (non-binding), and the new 2026 Stock Incentive Plan. The 2026 Plan, effective October 16, 2026, authorizes up to 2,500,000 new shares plus shares forfeited under the prior 2019 Plan. All director nominees received majority support, though Katrina L. Houde and Joshua E. Schechter faced notable opposition with over 3.3 million and 2.7 million votes withheld, respectively.

  • · The 2026 Stock Incentive Plan was approved with 22,724,492 votes for, 392,825 against, and 13,086 abstentions (broker non-votes: 10,697,326).
  • · Ratification of KPMG LLP as independent auditor was approved with 33,760,879 votes for, 63,445 against, and 3,405 abstentions.
  • · Advisory approval of executive compensation passed with 22,938,684 votes for, 178,868 against, and 12,851 abstentions (broker non-votes: 10,697,326).
  • · Two director nominees (Katrina L. Houde, Joshua E. Schechter) received more than 3.3 million and 2.7 million votes withheld, respectively, indicating notable shareholder dissent.
  • · The 2026 Plan becomes effective October 16, 2026, and the 2019 Plan will expire on that date.
  • · The record date for the meeting was April 6, 2026.
I-ON Digital Corp. 8-K positive materiality 7/10

05-06-2026

I-ON Digital Corp. (OTCQB: IONI) announced a binding agreement to acquire rights to 20 BLM gold mining claims in the southwestern U.S., expanding its gold claims pipeline for digitization. The acquisition is fully financed through cash, seller finance, treasury-held IONau gold assets, and I-ON common stock, with closing and digitization targeted for Q3 2026. While the transaction reduces execution risk due to advanced onboarding milestones, it remains subject to final geological review, reserve validation, and other customary closing conditions, with no assurance that all claims will meet onboarding requirements.

  • · The agreement includes a joint-venture operating option over additional mineral claims held by the seller, providing a structured pathway for future reserve growth without renegotiating mineral rights on a claim-by-claim basis.
  • · The initial funding tranche is being executed in collaboration with Real Asset Acquisition Corp. (https://raac.io).
  • · The Seller substantially completed I-ON's proprietary onboarding, verification, and reserve qualification process prior to opening escrow, accelerating the timeline.
  • · The acquisition is expected to support future development of site-specific mineral processing, recovery, storage, and vaulting capabilities.
OptimizeRx Corp 8-K neutral materiality 5/10

05-06-2026

OptimizeRx Corp announced the separation of Chief Commercial Officer Theresa Greco, effective June 15, 2026, with a separation agreement providing 12 months of base salary continuation ($380,000/year), a lump-sum cash bonus of $209,000, and COBRA reimbursement. Ms. Greco will serve as an advisor through June 15, 2027, with continued equity vesting and a potential change-in-control bonus. The departure is a planned executive transition, but the associated severance costs and advisory arrangement represent additional near-term expenses.

  • · Separation agreement includes a general release of claims and non-compete/non-solicit obligations for 12 months.
  • · Ms. Greco's equity grants will continue to vest during the advisory term.
  • · A special bonus may be payable upon a change in control during the advisory term per a September 8, 2025 agreement.
  • · The separation was previously disclosed in the Q1 2026 10-Q filed on May 11, 2026.
Dream Finders Homes, Inc. 8-K neutral materiality 4/10

05-06-2026

Dream Finders Homes appointed Clint Szubinski as Chief Operating Officer, effective immediately. The move strengthens the executive team as the company expands across the Southeast, Mid-Atlantic, and Midwest. No financial impact or concurrent financial results were disclosed.

  • · Mr. Szubinski previously served as EVP and COO at Meritage Homes, and as President of Meritage's East Region.
  • · He will work alongside National President Doug Moran to transition teams and responsibilities.
  • · DFH builds in Florida, Texas, Tennessee, North Carolina, South Carolina, Georgia, Colorado, Arizona, and the Washington, D.C. metro area.
  • · The company was recognized as the 2025 National Builder of the Year by Builder magazine.
Grindr Inc. 8-K neutral materiality 5/10

05-06-2026

Grindr Inc. held its 2026 annual meeting on June 2, 2026, where stockholders approved the amendment and restatement of the Grindr Inc. 2022 Equity Incentive Plan. The A&R Plan increases the share reserve by 11,600,000 shares, introduces stockholder approval requirements for repricing of stock options and stock appreciation rights, and mandates that dividends on unvested awards be accumulated and subject to the same vesting conditions as the underlying award.

  • · The A&R Plan introduces a requirement for stockholder approval for repricing of outstanding stock options and stock appreciation rights.
  • · Dividends or dividend equivalents on unvested awards will be accumulated and not paid until the underlying award vests, and will be forfeited if the award is forfeited.
  • · The detailed description of the A&R Plan was included in the definitive proxy statement filed on April 30, 2026.
AEVEX Corp. 8-K positive materiality 8/10

05-06-2026

AEVEX Corp. priced a follow-on public offering of 8,000,000 shares of Class A common stock at $27.00 per share on June 3, 2026, with the company selling 5,726,157 shares and selling stockholders selling 2,273,843 shares. The offering closed on June 5, 2026, and the underwriters have a 30-day option to purchase up to an additional 1,200,000 shares. The underwriting agreement includes customary representations, warranties, and indemnification provisions.

  • · The offering was priced at $27.00 per share, which is the public offering price.
  • · The underwriting agreement was entered into on June 3, 2026, and the offering closed on June 5, 2026.
  • · The underwriters have a 30-day option to purchase up to an additional 858,923 shares from the company and 341,077 shares from the selling stockholders.
  • · The offering was made pursuant to a registration statement on Form S-1 (File No. 333-296396).
  • · The company and selling stockholders agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act.
Tavia Acquisition Corp. 8-K neutral materiality 5/10

05-06-2026

Tavia Acquisition Corp. (TAVIR) entered into a promissory note with Tavia Sponsor Pte. Ltd. on June 5, 2026, allowing the company to draw up to $540,000 in monthly installments of $60,000 to fund its trust account until the earlier of a business combination, liquidation, or March 5, 2027. The note is non-interest bearing and matures upon consummation of the initial business combination or winding up, with the sponsor waiving any claims against the trust account. This financing supports the company's ongoing search for a merger target.

  • · The note is non-interest bearing.
  • · Drawdowns begin June 5, 2026, and occur monthly on the 5th until the earliest of: business combination consummation, March 5, 2027, or liquidation of the trust account.
  • · The sponsor waives any and all claims against the trust account.
  • · The note is governed by New York law.
  • · No fees or payments are due to the payee in connection with any drawdown.
NORTHERN MINERALS & EXPLORATION LTD. 8-K neutral materiality 7/10

05-06-2026

Northern Minerals & Exploration Ltd. (NMEX) entered into a Memorandum of Understanding on June 2, 2026, to acquire a 5.4165 net mineral acre leasehold interest in Garvin County, Oklahoma, associated with the proposed Bosworth 0203 1H-27X well. Total consideration is $21,666, comprising $10,833 in cash (payable by July 31, 2026) and $10,833 payable in 216,660 shares of NMEX common stock. The interest is expected to deliver a 77% net revenue interest, and the company must participate in an Oklahoma Corporation Commission force pooling order, covering its proportionate share of estimated drilling and completion costs.

  • · The agreement with R.A. Miller Energy, Inc. is dated May 20, 2026, and was executed on June 2, 2026.
  • · The leasehold is located in Sections 27 and 34, Township 2 North, Range 3 West, and Section 3, Township 1 North, Range 3 West, Garvin County, Oklahoma.
  • · The 216,660 shares will be issued in a private transaction exempt from registration under Section 4(a)(2) of the Securities Act.
  • · The company is required to participate in the Oklahoma Corporation Commission force pooling order and pay its proportionate share of estimated drilling and completion costs within applicable deadlines.

Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Material Events SEC 8-K Filings

🇺🇸 More from United States

View all →